RAPT Therapeutics Inc (RAPT) support and resistance · $132.1M cap
RAPT Therapeutics Inc (RAPT) is a biotechnology company listed on US.
This page maps RAPT Therapeutics Inc (RAPT) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported RAPT revenue for 2023-12-31 was $0. Net income was -$116.8M. Revenue was down 100.0% from 2022-12-31 to 2023-12-31. RAPT currently screens at market cap $132.1M.
RAPT currently screens at market cap $132.1M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new RAPT 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the RAPT quote page for the session range and the stock page for the full model.
Not investment advice.